Develops medical imaging devices for liver disease and other applications, focusing on enhanced ultrasound technologies.
ENDRA Life Sciences Inc. pioneers cutting-edge technology aimed at advancing clinical diagnostic ultrasound capabilities. Specializing in thermo-acoustic enhanced ultrasound, the company employs innovative methods where sound waves interact with tissues, organs, and blood within the body. This technology is instrumental in addressing conditions like nonalcoholic fatty liver disease, providing crucial applications in thermoablative surgery monitoring, vascular imaging, and tissue perfusion.
In addition to its groundbreaking ultrasound solutions, ENDRA Life Sciences Inc. offers a range of diagnostic imaging technologies such as computed tomography (CT), magnetic resonance imaging (MRI), and traditional ultrasound. These tools enable healthcare providers to gain detailed insights into internal bodily structures, aiding in the diagnosis and treatment of various medical conditions such as fractures, cancers, cardiac issues, and internal bleeding.
Founded in 2007 and headquartered in Ann Arbor, Michigan, ENDRA Life Sciences Inc. operates at the forefront of medical technology innovation. The company has forged strategic partnerships, including a notable research collaboration with General Electric Company, underscoring its commitment to advancing the field of medical imaging and ultrasound diagnostics.